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ABSTRACT
Objective. The aim of this study was 
to assess inflammatory changes within 
the knee joint of systemic lupus ery-
thematosus (SLE) patients by using 
ultrasound (US). Rheumatoid arthri-
tis (RA) patients and healthy subjects 
(HS) were evaluated as controls. US 
findings were correlated with disease 
activity parameters. 
Methods. Twenty-six SLE patients 
were enrolled in the study, 25 RA pa-
tients and 15 HS were selected as con-
trols. US was performed by two differ-
ent experienced operators, using an 
Agilent-HP Image point Hx machine 
equipped with a 10 MHz linear trans-
ducer. Power Doppler (PD) was used 
to determine local synovial perfusion 
(PFR 700-1100 Hz; gain 60-65dB; 
low filter). Knee joints were examined 
bilaterally. US findings, expressed af-
ter consensus of the 2 operators, were 
correlated to clinical and serological 
parameters of disease activity. Statisti-
cal analysis was performed by the EPI-
STAT program. 
Results. In SLE, synovitis was found 
in 21 knees (40%), joint effusion in 
12 (23%), synovial proliferation in 12 
(23%), positive PD signal in 5 (10%) 
and gastrocnemius-semimembranosus 
bursitis in 5 (10%). No erosions were de-
tected. There was a significant difference 
respect to RA for synovitis (p<0.003), 
synovial proliferation (p<0.002) and 
positive PD signal (p<0.01). No cor-
relation was found between US altera-
tions and SLE disease activity param-
eters. In the HS group 1 patient showed 
mild synovial proliferation. 
Conclusion. This is the first study that 
investigates knee joint involvement in 
SLE by ultrasonography. US was able 
to depict inflammatory alterations in 
the articular tissues of SLE patients, 
revealing some common characteris-
tics with RA, except for the presence 
of erosions. We believe that US might 
be of help in the global evaluation of 
SLE patients with inflammatory joint 
involvement, providing relevant infor-
mation to the clinician. 
Introduction
Lupus patients often complain about 
pain and swelling of joints, which may 
be caused by inflammation located in 
different articular tissues, sometimes 
difficult to discern during clinical ex-
amination. Musculoskeletal ultrasound 
(US) allows a direct comparison be-
tween clinical and anatomical findings, 
providing useful information that might 
influence the therapeutic approach (1). 
The US characteristics of joint effu-
sion, synovial proliferation and ero-
sions have been extensively described 
(2). Furthermore, power Doppler (PD) 
has become an essential part of US ex-
amination in inflammatory rheumatic 
diseases, given its ability to detect in-
creased haematic perfusion of the syn-
ovial membrane, which is considered 
an estimate of the level of local inflam-
mation (3). The distinction between 
inflammatory and non-inflammatory 
synovial tissue may be important for 
therapeutic purposes (4). 
We have previously described the al-
terations detected by US in the wrists of 
a group of patients with systemic lupus 
erythematosus (SLE) (5). Herein, we 
report the sonographic findings detected 
in the knees of the same patients, corre-
lating US data to clinical and laboratory 
parameters of disease activity.
Patients and methods
Twenty-six SLE patients fulfilling the 
American College of Rheumatology 
(ACR) criteria for the disease were 
consecutively enrolled in the study 
from the in- and out-patient popula-
tion of the Rheumatology Unit of the 
“Sapienza” University of Rome, Italy, 
as previously reported (5, 6). The study 
was conducted in compliance with the 
protocol, good clinical practices and 
the Declaration of Helsinki principles. 
The patients underwent a medical ex-
amination in which the following in-
formation was recorded: demographic 
data, past and recent medical history, 
disease duration (expressed in years 
from the first diagnosis), number of 
painful and swollen joints, current 
therapy and SLE Disease Activity In-
dex (SLEDAI). On the same occasion, 
a blood sample was collected from 
each patient to calculate, in our labo-
ratory, levels of erythrocyte sedimenta-
tion rate (ESR) (normal value <15mm/
h) and C3 (normal value >70mg/dl), 
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which were considered as laboratory 
disease activity parameters. C4 was not 
measured because of the potential bias 
due to genetic deficiencies (7). All data 
were later transferred to a computer da-
tabase. The control groups consisted of 
25 rheumatoid arthritis (RA) patients 
diagnosed according to the ACR criter-
ia and consecutively recruited from the 
same in- and out-patient population and 
in the same period of SLE patients (8), 
and of 15 healthy subjects (HS) sex- 
and age-matched with SLE patients . 
On the same day of the clinical assess-
ment, patients and controls underwent 
an US evaluation of both knees. The 
exam was performed by two independ-
ent rheumatologists, experienced in 
musculoskeletal US (AO, AI), blinded 
to the subject diagnosis, clinical and 
laboratory data. Each examination was 
performed twice and separately by the 
two operators. Alterations were record-
ed in both longitudinal and transverse 
scans according to EULAR guidelines 
for musculoskeletal US in rheumatol-
ogy (9). Power Doppler was applied 
in all the performed scans analysing 
the synovial tissue. The final results 
were expressed by consensus of the 2 
operators analysing the stored images. 
An Agilent-HP Image point Hx, with a 
10 MHz linear transducer, capacitated 
with PD (PFR 700-1100 Hz; gain 60-
65 dB; low filter) was used.
The following parameters were evalu-
ated by US according to literature data 
(3, 9-11): synovial proliferation, de-
fined as the presence of hypertrophic 
and thickened synovial tissue in the 
joint; positive power-Doppler, defined 
as a high colour persistence of the 
power-Doppler signal in the synovial 
tissue; joint effusion, defined as an in-
trarticular anechoic/hypoechoic fluid 
collection determining capsular dis-
tension; synovitis, defined as the pres-
ence of synovial proliferation and/or 
joint effusion with or without positive 
PD signal; bone erosions, defined as a 
cortical break or defect with an irregu-
lar floor, seen in both longitudinal and 
transverse scans; gastrocnemius-semi-
membranosus (GS) bursitis, defined as 
a fluid distension of the bursa with pos-
sible presence of local synovial prolif-
eration. All data were recorded with the 
“absent-present” criterion.
Statistical analysis
Data analysis was performed using the 
EPISTAT program. Chi-square and 
Fisher’s exact test were used to com-
pare qualitative differences between 
the groups, while the student t-test was 
chosen to compare quantitative param-
eters in large samples of similar vari-
ance. The findings were expressed by 
mean and standard deviation from the 
mean. Values of p<0.05 were consid-
ered to be statistically significant. 
Results 
Demographic and clinical data of SLE 
patients and controls are shown in 
Table I. For the majority of patients, 
treatment was based on corticosteroids 
± various different Disease Modifying 
Anti-Rheumatic Drugs (hydroxycloro-
quine, cyclosporine, methotrexate and 
cyclophosphamide). As there was a 
great variability between patient treat-
ments, we decided not to divide patients 
according to the different dosages and 
administered drugs. 
Fifty-two knees of patients with SLE, 
50 of patients with RA and 30 of HS 
were examined by US. The results are 
reported in Table II. 
Twenty knees in SLE, 35 knees in RA 
and 1 knee in HS, showed at least one 
alteration on US scanning. US was able 
to detect inflammatory changes due to 
synovitis in intrarticular structures in 
14 patients (37.8%) having a negative 
physical examination at the investigat-
ed joint.  HS did not show any of the 
considered alterations, except for one 
patient with mild synovial proliferation 
and no symptoms at the joint. As ex-
pected, pathological findings suggestive 
of joint inflammation were more preva-
lent in RA than in SLE patients (Fig. 1). 
Signs of synovitis were detected in 21 
knees (40%) of 15 SLE patients (58%), 
versus 31 knees (62%) of 18 RA patients 
(72%) (p<0.003). The major alteration 
depicted in SLE was joint effusion, de-
tected in 12 knees (23%) of 8 patients 
(31%): for this parameter, there was no 
statistical difference with RA. Synovial 
proliferation was present in 12 knees 
(23%) of 11 SLE patients (42%), while 
a positive PD signal was present in 5 
knees (10%) of 4 SLE patients (15%). 
Both parameters were more prevalent 
in RA, with a significant statistical dif-
ference. GS bursitis was detected in 5 
knees (10%) of 4 SLE patients (15%), 
showing no statistical difference with 
Table I. Demographic and clinical data of SLE and RA patients.
Patients SLE (26) RA (25) HS (15) p-value*
Age (years), Mean ± SD, (range)  40 ± 10, (23-64) 51 ± 15, (24-72) 40 ±12, (20-60) 0.005 RA vs. SLE, and HS
F/M, ratio 23/3, 8:1 22/3, 7:1 13/2, 6.5:1 NS
Disease duration (years), Mean ± SD, (range) 15 ± 7, (1-27) 13.4 ± 13, (0-40) – NS 
No. of total tender joints per patient 3.2 ± 5, (0-21) 6.4 ± 6, (0-17) 0,7±1.3, (0-4) 0,03 RA vs. SLE
    Mean  ± SD, (range)    0.001 RA vs. HS
No. of tender knee joints, percentage 15 (28.8%) 20 (40%) 0 NS
No. of swollen knee joints, percentage 1(1.9%) 9 (18%) 0 0,008 RA vs. SLE
ESR (mm/hr) 29 ± 28, (4-101) 31 ± 16, (8-66) 11±5, (2-16) 0.0003 RA vs. HS
    Mean  ± SD, (range)    0,04 SLE vs. HS
C3 values (mg/dl), Mean  ± SD, (range)  111 ± 43, (38-173) – – –
SLEDAI score Mean  ± SD 2 ±1.0 – – –
SLE: systemic lupus erythematosus; RA: rheumatoid arthritis; HS: healthy subjects; SD: standard deviation; F: female; M: male; ESR: erythrocyte sedimen-
tation rate; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; NS: not significant; *results not shown were not significant.
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RA. We did not find any erosions in the 
SLE group. 
Finally, US alterations were not sig-
nificantly associated to disease activity 
parameters evaluated by ESR, C3, and 
SLEDAI.
Discussion 
Extensive literature exists on the use-
fulness of US as a diagnostic and mon-
itoring tool in several rheumatologic 
diseases, such as RA (12, 13), psoriatic 
arthritis (14, 15), and negative spondy-
loarthritis (16). Recently, an elegant 
review by Riente and colleagues pro-
vided an update on the available data 
concerning the application of US in 
connective tissue diseases (17). PD has 
added important information regarding 
inflammation in the synovial tissue, as 
highlighted by the work of Schmidt 
and colleagues, which confronted color 
Doppler findings with histological re-
sults in the knees of patients with RA 
and osteoarthritis (18). 
To our knowledge, after our publication, 
only Wright and colleagues have studied 
SLE joint involvement, describing hand 
and wrist alterations by a pictorial assay 
(19). A recent case report by Saketkoo 
and collegues, has also been published 
on the less common deformities in SLE 
caused by Jaccoud’s  arthropathy (20). 
Thus, new studies are needed to further 
elucidate joint involvement in SLE, 
considering that joints symptoms are 
one of the most frequent manifestations 
at onset, time of diagnosis and follow 
up, with a prevalence in up to 85% of 
the patients (21). 
In our study, we examined the knees of 
26 SLE patients by US and compared 
the results with those found in RA pa-
tients and HS. SLE showed an unex-
pected high prevalence of inflammatory 
pathological changes (synovitis in up to 
40% of the examined joints), although 
US joint alterations were more frequent 
in RA for all the considered parameters, 
reflecting the greater articular involve-
ment clinically observed in this group 
of patients. Interestingly, in SLE, joint 
effusion did not show a statistical dif-
ference in frequency with respect to 
RA, while synovial proliferation and 
positive PD varied significantly be-
tween the two diseases (p<0.002 and 
p<0.01 respectively). These findings 
probably reflect a milder joint inflam-
matory process in SLE, given by the 
different pathophysiological pathways 
involved in the two diseases and con-
firmed by the clinical experience of a 
less severe and destructive pattern of 
joint involvement (22). Concordantly, 
the absence of erosions in our SLE pa-
tients supports the assertion by which 
the inflammatory process does not 
probably reach, in most cases, the nec-
essary degree of aggressiveness needed 
to produce an interruption of the bone 
surface. A well-known exception is 
the clinical subset of Rhupus, which 
is characterized by an overlap between 
SLE and RA features (23). 
We did not detect signs of synovial 
proliferation in the knees of patients 
in which there was a normal amount 
of synovial fluid. For this parameter 
there might be a bias due to the fact 
that in the absence of anechoic collec-
tion within the joint cavity, it is often 
more difficult to highlight the presence 
of synovial thickening. Interestingly, 
SLE and RA did not differ statistically 
for the presence of GS bursitis, which 
is a relatively common pathological 
finding in patients with painful knee by 
different causes (24). Since the aim of 
the study was to define inflammatory 
changes due to synovitis in intrarticu-
lar structures, several pathologic con-
ditions were not recorded, such as the 
alterations of cartilage and bones due 
to osteoarthritis or orthopaedic diseas-
es. Nevertheless, it could be important 
to document the presence of concomi-
tant pathologies in this typology of pa-
tients, since they may influence some 
US findings such as the presence of 
joint effusion. 
Interestingly, US was able to reveal in-
flammation in 37.8% knees of asymp-
tomatic patients showing a negative 
physical examination. The concept 
that physical exam may underestimate 
knee inflammation has been previously 
reported (25). 
The lack of correlation between system-
ic disease activity parameters (number 
of symptomatic joints, ESR, C3, 
SLEDAI) and US joint findings, stress-
es once again the importance of a global 
assessment of the patient, which may 
include US as an imaging technique 
Table II. Comparison of ultrasonographic findings in SLE and RA. 
Joints US findings SLE RA HS
  (52 knees) (50 knees) (30 knees)
Knee Synovial proliferation 12 28* 1
 Positive PD signal 5 17** 0
 Joint effusion 12 16 0
 Erosions 0 9*** 0
 GS bursitis 5 8 0
SLE: systemic lupus erythematosus; RA: rheumatoid arthritis; HS: healthy subjects; PD: power. 
Doppler,*p<0.002, **p<0.01, ***p<0.001.
Fig. 1. US examination of the knee; Suprapatellar transverse scan. Left: systemic lupus erythemato-
sus:  mild joint effusion  and synovial proliferation. Right: rheumatoid arthritis: severe joint effusion 
with evident signs of synovial proliferation.  
f: femur; *: joint effusion in the suprapatellar pouch; arrowhead: synovial proliferation. 
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able to show disease activity at a local 
level. Pain and inflammation in a joint 
might not be accompanied by other im-
portant signs of systemic disease or by 
major organ involvement, thus SLEDAI 
might not be the appropriate tool to as-
sess local disease activity, although the 
small sample size does not allow us to 
draw firm conclusions on this. 
US has many advantages over other im-
aging techniques such as conventional 
radiography or MRI: it is safe, it has 
low costs of management, and provides 
repeatability and reproducibility, ac-
companied by a good patients’ accept-
ance (26). The use of a multiplannar 
scanning technique offers the chance to 
visualize and confirm alterations in dif-
ferent planes and to explore broad areas 
of the joint. Assessment of international 
accepted guidelines and recent defini-
tion of ultrasonographic pathology have 
significantly improved the reliability of 
US, which is still greatly influenced by 
the operator experience and capability 
(27, 28).
New fields of research, such as the use 
of ultrasound contrast agents to better 
evaluate the degree of synovial mem-
brane vascularization and three dimen-
sional US, are probably going to em-
power the potential of this imaging tool 
in the study of rheumatic diseases (29). 
Moreover, US can be useful in moni-
toring the effects of therapy, suggesting 
a potential future role for this technique 
in treatment decision changes (30). 
In conclusion, this is the first study that 
analyses knee joint alterations in SLE 
by US. In our lupus patients, US was 
able to depict inflammatory changes 
and to detect the presence of active 
synovitis by the use of power-Doppler. 
Even though we did not detect any ero-
sion in our SLE patients, our overall 
results show common characteristics 
between the two diseases for many of 
the detected knee joint alterations, thus 
differential diagnosis between lupus 
and RA must not rely on US findings. 
In the expert hands of the rheumatolo-
gist, who knows the clinical patterns 
and pathogenesis of the disease that 
produce the different anatomic altera-
tions, US represents a valuable tool, 
complementary rather than competitive 
with other imaging techniques. Thus, 
we believe that US examination should 
be included in the global evaluation of 
SLE patients with articular symptoms, 
especially in those cases in which phys-
ical examination is not conclusive.  
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